Electrocardiographic criteria of left ventricular hypertrophy in general population

Edoardo Casiglia1, Laura Schiavon, Valérie Tikhonoff

  • 1Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. edoardo.casiglia@unipd.it

Insights

Electrocardiographic (ECG) criteria are unreliable for detecting left ventricular hypertrophy (LVH) in the general population due to low positive predictive value. Echocardiography is preferred for initial LVH diagnosis, though ECG may aid in outcome prediction for diagnosed cases.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Public Health

Background:

  • Left ventricular hypertrophy (LVH) detection and prognostic value of electrocardiographic (ECG) criteria remain debated.
  • Population-based studies are crucial for validating diagnostic tools in unselected individuals.

Purpose of the Study:

  • To assess the reliability of various ECG criteria for detecting LVH in a general population sample.
  • To evaluate the role of ECG-diagnosed LVH in predicting mortality compared to echocardiography.

Main Methods:

  • 1,699 subjects from the general population underwent echocardiography and standard ECG.
  • ECG was codified for LVH using Minnesota code and five other methods.
  • Left ventricular mass index (LVMI) and mortality data were analyzed alongside ECG and echocardiographic findings.

Main Results:

  • Prevalence of echocardiographic LVH was 36.6% in men and 53.4% in women.
  • ECG criteria showed low sensitivity and predictive value for LVH detection, despite high specificity.
  • LVH diagnosed by echocardiogram or Sokolow-Lyon ECG criterion independently predicted mortality.

Conclusions:

  • ECG criteria are not a reliable substitute for echocardiography in detecting LVH in the general population due to low positive predictive value.
  • ECG may be useful for outcome prediction in individuals with previously confirmed LVH via echocardiography or specific ECG criteria.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...